Business
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~ ~SImmetry+'s New 3D printed titanium implants, robust joint decorticator, ...
About this update from Tenon Medical, Inc.
[{"type":"text","content":"~Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~","length":185,"tagName":"p"},{"type":"text","content":"~SImmetry+'s New 3D printed titanium implants, robust joint decorticator, and simple bone graft delivery system provides physicians treatment options rooted in established fusion principles~","length":194,"tagName":"p"},{"type":"text","content":"~Company initiating alpha launch of SImmetry® + with select group of physician users to provide initial feedback to support broader launch~","length":147,"tagName":"p"},{"type":"text","content":"LOS GATOS, CA / ACCESS Newswire / October 21, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SImmetry+ SI Joint Fusion System. The SImmetry+ System is indicated for sacroiliac (SI) joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis, providing physicians with treatment options rooted in established fusion principles.","length":590,"tagName":"p"},{"type":"text","content":"Utilizing the systems new 3D printed titanium implants and proprietary instrumentation, the SImmetry+ is a novel minimally invasive lateral access SI joint fusion system that uses proven orthopedic principles, including joint decortication, bone graft delivery, and fixation to achieve a true fusion. The Company is finalizing preparation for the initial alpha launch of the SImmetry+ targeting a launch by the end of the year. The alpha will provide important initial user feedback from a select group of physician users to support a broader market introduction in the coming months.","length":584,"tagName":"p"},{"type":"text","content":"With this clearance, SImmetry+ now joins Tenon's Catamaran® SI Joint Fusion System in the Company's growing portfolio of advanced technologies. Together, these platforms uniquely position Tenon with multiple surgical approaches-lateral and inferior-posterior-both designed to be minimally invasive, enable authentic arthrodesis and supported by robust clinical evidence, including t...